Publications by authors named "Hollis Lin"

Claim this Profile
E
Effectiveness of patisiran after switching from tafamidis for the treatment of hereditary transthyretin-mediated amyloidosis with polyneuropathy.
Celine Labeyrie, Madeline Merkel, Sakshi Sethi, Lyuba Popadic, Hongbo Yang, Hollis Lin

Eur J Neurol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Indirect treatment comparison (ITC) of the efficacy of vutrisiran and tafamidis for hereditary transthyretin-mediated amyloidosis with polyneuropathy.
Madeline Merkel, David Danese, Chongshu Chen, Jessie Wang, Aozhou Wu, Hollis Lin

Expert Opin Pharmacother· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Indirect treatment comparison of the efficacy of patisiran and inotersen for hereditary transthyretin-mediated amyloidosis with polyneuropathy.
Peter Gorevic, Jaclyn Franklin, Jihong Chen, Gautam Sajeev, Jessie C H Wang, Hollis Lin

Expert Opin Pharmacother· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Experience of patisiran with transthyretin stabilizers in patients with hereditary transthyretin-mediated amyloidosis.
Hollis Lin, Madeline Merkel, Cecilia Hale, Jing L Marantz

Neurodegener Dis Manag· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating Prognostic Factors for Liver Transplantation Among United States Patients With Hereditary Transthyretin-Mediated (hATTR) Amyloidosis Using National Registry Data.
Danielle Brandman, Hollis Lin, Anastasia McManus, Sonalee Agarwal, Larry M Gache

Prog Transplant· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to the letter to the editor on "an indirect treatment comparison of the efficacy of patisiran and tafamidis for the treatment of hereditary transthyretin-mediated amyloidosis with polyneuropathy".
Hollis Lin, Sonalee Agarwal, Marissa Betts, Kyle Fahrbach, Madhura Chitnis

Expert Opin Pharmacother· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An indirect treatment comparison of the efficacy of patisiran and tafamidis for the treatment of hereditary transthyretin-mediated amyloidosis with polyneuropathy.
Violaine Planté-Bordeneuve, Hollis Lin, Jared Gollob, Sonalee Agarwal, Marissa Betts

Expert Opin Pharmacother· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intermediate Services After Behavioral Health Hospitalization: Effect on Rehospitalization and Emergency Department Visits.
Catherine A Fullerton, Hollis Lin, Peggy L O'Brien, Gregory M Lenhart, Erika L Crable

Psychiatr Serv· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient factors contributing to variation in same-hospital readmission rate.
Rachel Mosher Henke, Zeynal Karaca, Hollis Lin, Lauren M Wier, William Marder

Med Care Res Rev· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis